High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors

Blood

Volumn 98, Issue 9, 2001, Pages 2664-2672

  Moreau Gaudry, Francois ^a   Xia, Ping ^a,b   Jiang, Gang ^c,d   Perelman, Natalya P ^e,f   Bauer, Gerhard ^g   Ellis, James ^b   Surinya, Katherine H ^a,b   Mavilio, Fulvio ^a   Shen, Che Kun ^a   Malik, Punam ^a,f,g,h  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g ACADEMIA SINICA   (Taiwan)

^h CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ANKYRIN; BETA GLOBIN; GAMMA GLOBIN; GREEN FLUORESCENT PROTEIN; HEAT SHOCK PROTEIN 40; TRANSCRIPTION FACTOR GATA 1;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; BURST FORMING UNIT E; CELL SPECIFICITY; ENHANCER REGION; ERYTHROID CELL; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HEMOGLOBINOPATHY; HEPATITIS VIRUS; HUMAN; HUMAN CELL; HYBRID GENE; LENTIVIRINAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; VIRAL GENE DELIVERY SYSTEM; VIRUS TRANSMISSION;

EID: 0035525735     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.9.2664     Document Type: Article

References (54)

1. Sadelain M, Wang CH, Antoniou M, Grosveld F, Mulligan RC. Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. Proc Natl Acad Sci U S A. 1995;92:6728-6732.
2. Walsh CE, Liu JM, Miller JL, Nienhuis AW, Samulski RJ. Gene therapy for human hemoglobinopathies. Proc Soc Exp Biol Med. 1993;204:289-300.
3. Dzierzak EA, Papayannopoulou T, Mulligan RC. Lineage-specific expression of a human betaglobin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature. 1988;331:35-41.
4. Emerman M, Temin HM. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 1984;39:449-467.
5. Emerman M, Temin HM. Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol Cell Biol. 1986;6:792-800.
6. Emerman M, Temin HM. Comparison of promoter suppression in avian and murine retrovirus vectors. Nucleic Acids Res. 1986;14:9381-9396.
7. Yu SF, von Ruden T, Kantoff PW, et al. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A. 1986;83:3194-3198.
8. Yee JK, Moores JC, Jolly DJ, Wolff JA, Respess JG, Friedmann T. Gene expression from transcriptionally disabled retroviral vectors. Proc Natl Acad Sci U S A. 1987;84:5197-5201.
9. Buchman AR, Berg P. Comparison of intron-dependent and intron-independent gene expression. Mol Cell Biol. 1988;8:4395-4405.
10. Collis P, Antoniou M, Grosveld F. Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression. EMBO J. 1990;9:233-240.
11. Huang Y, Wimler KM, Carmichael GG. Intronless mRNA transport elements may affect multiple steps of pre-mRNA processing. EMBO J. 1999;18:1642-1652.
12. Custodio N, Carmo-Fonseca M, Geraghty F, Pereira HS, Grosveld F, Antoniou M. Inefficient processing impairs release of RNA from the site of transcription. EMBO J. 1999;18:2855-2866.
13. Antoniou M, Geraghty F, Hurst J, Grosveld F. Efficient 3′-end formation of human beta-globin mRNA in vivo requires sequences within the last intron but occurs independently of the splicing reaction. Nucleic Acids Res. 1998;26:721-729.
14. Antoniou M, deBoer E, Habets G, Grosveld F. The human beta-globin gene contains multiple regulatory regions: identification of one promoter and two downstream enhancers. EMBO J. 1988;7:377-384.
15. Huang ZM, Yen TS. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol Cell Biol. 1995;15:3864-3869.
16. Jiang G, Perelman N, Xu D, Leboulch P, Pepper KA, Malik P. The woodchuck hepatitis virus posttranscriptional regulatory element greatly increases titers from retroviral vectors and improves expression of the beta globin cDNA. Blood. 1999;94:176a.
17. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [see comments]. Science. 1996;272:263-267.
18. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science. 1999;283:682-686.
19. Case SS, Price MA, Jordan CT, et al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci U S A. 1999;96:2988-2993.
20. Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol. 1998;72:9873-9880.
21. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol. 1998;72:8150-8157.
22. Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol. 1998;9:457-463.
23. Grande A, Piovani B, Aiuti A, Ottolenghi S, Mavilio F, Ferrari G. Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells. Blood. 1999;93:3276-3285.
24. Surinya KH, Cox TC, May BK. Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem. 1998;273:16798-16809.
25. Huang BL, Fan-Chiang IR, Wen SC, et al. Derepression of human embryonic zeta-globin promoter by a locus-control region sequence. Proc Natl Acad Sci U S A. 1998;95:14669-14674.
26. Boulanger L. Etude de la regulation du gene alpha-spectrine: contribution a l'etude de l'elliptocytose hereditaire [thesis/dissertation]. Paris, France: Paris 7 University; 1997.
27. Bassères DS, Bordin S, Costa FF, Gallagher PG, Saad ST. A novel ankyrin promoter mutation associated with hereditary spherocytosis. Blood. 1998;92:8a-9a.
28. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol. 1999;73:2886-2892.
29. Rubin JE, Pasceri P, Wu X, Leboulch P, Ellis J. Locus control region activity by 5′HS3 requires a functional interaction with beta-globin gene regulatory elements: expression of novel beta/gamma-globin hybrid transgenes. Blood. 2000;95:3242-3249.
30. Malik P, Fisher TC, Barsky LL, et al. An in vitro model of human red blood cell production from hematopoietic progenitor cells. Blood. 1998;91:2664-2671.
31. Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci U S A. 1997;94:10319-10323.
32. Rivella S, Sadelain M. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. Semin Hematol. 1998;35:112-125.
33. Sabath DE, Koehler KM, Yang WQ, Patton K, Stamatoyannopoulos G. Identification of a major positive regulatory element located 5′ to the human zeta-globin gene. Blood. 1995;85:2587-2597.
34. Zhang Q, Rombel I, Reddy GN, Gang JB, Shen CK. Functional roles of in vivo footprinted DNA motifs within an alpha-globin enhancer: erythroid lineage and developmental stage specificities. J Biol Chem. 1995;270:8501-8505.
35. Emery DW, Chen H, Li Q, Stamatoyannopoulos G. Development of a condensed locus control region cassette and testing in retrovirus vectors for A gamma-globin. Blood Cells Mol Dis. 1998;24:322-339.
36. Emery DW, Morrish F, Li Q, Stamatoyannopoulos G. Analysis of gamma-globin expression cassettes in retrovirus vectors. Hum Gene Ther. 1999;10:877-888.
37. Ren S, Wong BY, Li J, Luo XN, Wong PM, Atweh GF. Production of genetically stable high-titer retroviral vectors that carry a human gamma-globin gene under the control of the alpha-globin locus control region. Blood. 1996;87:2518-2524.
38. Robertson G, Garrick D, Wu W, Kearns M, Martin D, Whitelaw E. Position-dependent variegation of globin transgene expression in mice. Proc Natl Acad Sci U S A. 1995;92:5371-5375.
39. Sharpe JA, Wells DJ, Whitelaw E, Vyas P, Higgs DR, Wood WG. Analysis of the human alpha-globin gene cluster in transgenic mice. Proc Natl Acad Sci U S A. 1993;90:11262-11266.
40. Sharpe JA, Summerhill RJ, Vyas P, Gourdon G, Higgs DR, Wood WG. Role of upstream DNase I hypersensitive sites in the regulation of human alpha globin gene expression. Blood. 1993;82:1666-1671.
41. Chen H, Lowrey CH, Stamatoyannopoulos G. Analysis of enhancer function of the HS-40 core sequence of the human alpha-globin cluster. Nucleic Acids Res. 1997;25:2917-2922.
42. Morley BJ, Abbott CA, Sharpe JA, Lida J, ChanThomas PS, Wood WG. A single beta-globin locus control region element (5′ hypersensitive site 2) is sufficient for developmental regulation of human globin genes in transgenic mice. Mol Cell Biol. 1992;12:2057-2066.
43. Reddy PM, Shen CK. Protein-DNA interactions in vivo of an erythroid-specific, human beta-globin locus enhancer. Proc Natl Acad Sci U S A. 1991;88:8676-8680.
44. Reddy PM, Shen CK. Erythroid differentiation of mouse erythroleukemia cells results in reorganization of protein-DNA complexes in the mouse beta maj globin promoter but not its distal enhancer. Mol Cell Biol. 1993;13:1093-1103.
45. Leboulch P, Huang GM, Humphries RK, et al. Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure. EMBO J. 1994;13:3065-3076.
46. Takekoshi KJ, Oh YH, Westerman KW, London IM, Leboulch P. Retroviral transfer of a human beta-globin/delta-globin hybrid gene linked to beta locus control region hypersensitive site 2 aimed at the gene therapy of sickle cell disease. Proc Natl Acad Sci U S A. 1995;92:3014-3018.
47. May C, Rivella S, Callegari J, et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human betaglobin. Nature. 2000;406:82-86.
48. Gallagher PG, Sabatino DE, Romana M, et al. A human beta-spectrin gene promoter directs high level expression in erythroid but not muscle or neural cells. J Biol Chem. 1999;274:6062-6073.
49. Sabatino DE, Cline AP, Gallagher PG, et al. Substitution of the human beta-spectrin promoter for the human agamma-globin promoter prevents silencing of a linked human beta-globin gene in transgenic mice. Mol Cell Biol. 1998;18:6634-6640.
50. Lazarides E, Moon RT. Assembly and topogenesis of the spectrin-based membrane skeleton in erythroid development. Cell. 1984;37:354-356.
51. Sabatino DE, Wong C, Cline AP, et al. A minimal ankyrin promoter linked to a human gamma-globin gene demonstrates erythroid specific copy number dependent expression with minimal position or enhancer dependence in transgenic mice. J Biol Chem. 2000;15:28549-28554.
52. Huang ZM, Yen TS. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol Cell Biol. 1995;15:3864-3869.
53. Sabatino DE, Seidel NE, Aviles-Mendoza GJ, et al. Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter. Proc Natl Acad Sci U S A. 2000;97:13294-13299.
54. Moreau-Gaudry F, Richard E, Xia P, et al. Successful gene therapy in a murine model of erythropoietic protoporphyria with a self inactivating erythroid-specific lentiviral vector [abstract]. Blood. 2000;96:590a.